🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Changchun
Clinical trial register · China

Clinical Trials in Changchun, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Changchun 47
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca102 The First Hospital of Jilin University47 Hoffmann-La Roche31 Janssen Research & Development, LLC30 Eli Lilly and Company23 Clear sponsor filter
Site location
Changchun47
All 1 locations
Target enrolment
to

Trials with a site in Changchun

47 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophageal Junction Cancer
NCT07790809Siewert Type II/III Gastroesophageal Junction Adenocarcinoma
The First Hospital of Jilin University
Not applicable
25
Changchun
2026-08-20
Active, closed
Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or Without SHR-1701 as Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
NCT07806110Pancreas Ductal Adenocarcinoma
The First Hospital of Jilin University
Phase 2
62
Changchun
2026-07-30
By invitation
Establishment of a Sleep and Sleep-disorder Research Cohort in Patients With Neurological Disorders
NCT07374393Sleep, Neurology
The First Hospital of Jilin University
Observational
100
Changchun
2026-07-04
Active, closed
The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression
NCT07179913Depressed, Bariatric Surgery
The First Hospital of Jilin University
Phase 4
40
Changchun
2026-05-01
Not yet open
Hybrid Deep Learning Integrating Multimodal CEUS and Enhanced MRI to Optimize Early-Stage HCC Treatment Decisions
NCT07582419Hepatocellular Carcinoma (HCC)
The First Hospital of Jilin University
Observational
1,424
Changchun
2026-04-30
Recruiting
Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
NCT07400302Mucosal Melanoma, PD-L1 Positive
The First Hospital of Jilin University
Phase 2
220
Changchun
2026-04-10
Recruiting
The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-preserving Surgery
NCT07369531Rectal Cancer, Surgical Anastomosis, Survival , Tumor, Anal Function
The First Hospital of Jilin University
Not applicable
520
Changchun
2026-03-18
Recruiting
Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria
NCT07505472Rectal Cancer
The First Hospital of Jilin University
Phase 2/3
212
Changchun
2026-02-23
Not yet open
Effect of Individualized Catheter Management on Early Removal After Rectal Cancer Surgery
NCT07346586Urinary Catheters, Rectal Cancer, Urinary Retention
The First Hospital of Jilin University
Not applicable
1,545
Changchun
2026-02-20
By invitation
Innovative Probe With Laser on Radial Artery Puncture and Catheterisation in Paediatric
NCT07454005Radial Artery Catheterization, Paediatric, Ultrasound Guided
The First Hospital of Jilin University
Not applicable
408
Changchun
2026-02-11
By invitation
In-plane Versus Real Time Bi-plane Single-operator Laser-assisted With a Innovative T-shaped Probe for Ultrasound-guided Internal Jugular Vein Catheterization:A Randomized Controlled Trial
NCT06958731Catheterization, Central Venous, Ultrasound Guided
The First Hospital of Jilin University
Not applicable
352
Changchun
2026-01-12
Recruiting
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
NCT07509086Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia (PCL)
The First Hospital of Jilin University
Phase 2
25
Changchun
2025-12-29
Recruiting
New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer
NCT07559760Metastatic Colorectal Cancer
The First Hospital of Jilin University
Phase 2
30
Changchun
2025-11-01
Recruiting
Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1)
NCT07495397Epithelial Ovarian Cancer
The First Hospital of Jilin University
Not applicable
98
Changchun
2025-11-01
Not yet open
RATME Vs LATME in Middle and Low Rectal Cancer
NCT06105203Total Mesorectal Excision, Rectal Neoplasms, Robotic Surgical Procedures, Laparoscopy
The First Hospital of Jilin University
Not applicable
1,026
Changchun
2025-11-01
Recruiting
Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in Critically Ill Patients
NCT07178626Critically Ill Patients Who Are Not Allowed to Eat Orally But Can Initiate Enteral Nutrition Within 48 Hours of ICU
The First Hospital of Jilin University
Observational
160
Changchun
2025-10-20
Not yet open
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
NCT07207681Advanced Solid Tumors
The First Hospital of Jilin University
Phase 1
30
Changchun
2025-10-15
Recruiting
The PRE-VAIL Study
NCT07176624ARDS (Moderate or Severe), Prone Position, Enteral Nutrition Feeding, Intensive Care Unit (ICU) Admission
The First Hospital of Jilin University
Not applicable
259
Changchun
2025-09-14
Recruiting
Nefecon and Ambrisentan in IgA Nephropathy
NCT07030894IgA Nephropathy, Chronic Kidney Disease, Proteinuria
The First Hospital of Jilin University
Phase 4
129
Changchun
2025-09-01
Recruiting
The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
NCT07151885Liver Cirrhosis, Esophageal and Gastric Varices
The First Hospital of Jilin University
Not applicable
380
Changchun
2025-08-31
Recruiting
Investigation of Protein Heterogeneity in Extracellular Vesicles Derived From Different Human Blood Circulatory Regions
NCT07439965Subarachnoid Aneurysm Hemorrhage, Unruptured Intracranial Aneurysm
The First Hospital of Jilin University
Observational
120
Changchun
2025-07-29
Recruiting
Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection
NCT07493824Persistent HR-HPV Infection of the Cervix
The First Hospital of Jilin University
Phase 4
115
Changchun
2025-07-24
Recruiting
Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
NCT06957093Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)
The First Hospital of Jilin University
Not applicable
400
Changchun
2025-06-15
Not yet open
Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study
NCT07003464Chronic Lymphocytic Leukemia
The First Hospital of Jilin University
Phase 2
30
Changchun
2025-06-15
By invitation
Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment
NCT06914661Breast Cancer Metastatic, Efficacy and Safety
The First Hospital of Jilin University
Observational
200
Changchun
2025-05-25
Recruiting
Comparison of the Diagnostic Performance of Different Artificial Intelligence Assisted Endocytoscopy for Colorectal Lesions
NCT06982872Endocytoscopy
The First Hospital of Jilin University
Observational
500
Changchun
2025-05-21
Recruiting
Clinical Study on the Diagnosis of Colorectal Lesions by Real-time Artificial Intelligence Assisted Endocytoscopy Combined With Narrow Band Imaging
NCT06982885Endocytoscopy
The First Hospital of Jilin University
Observational
500
Changchun
2025-05-19
Recruiting
Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
NCT06875076Pretreated Pleural Mesothelioma
The First Hospital of Jilin University
Phase 2
25
Changchun
2025-03-08
Recruiting
mNEED: a Multicentre, Cluster-randomized, Controlled Trial
NCT06827275Feeding, ICU
The First Hospital of Jilin University
Not applicable
2,250
Changchun
2025-02-25
Recruiting
Clinical Study on the Accuracy of Real-time AI-assisted Endocytoscopy in the Diagnosis of Colorectal Diminutive Polyps
NCT06791408Colorectal Polyp
The First Hospital of Jilin University
Observational
600
Changchun
2025-02-05
Active, closed
Antibiotic Exposure on Gut Microbiota and Motility Establishment in Newborns
NCT06850896NEC - Necrotizing Enterocolitis
The First Hospital of Jilin University
Observational
200
Changchun
2025-02-01
Recruiting
A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer
NCT06979908Metastatic Colorectal Cancer
The First Hospital of Jilin University
Phase 2
46
Changchun
2025-01-22
Recruiting
Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study
NCT07495384Recurrent Ovarian Cancer, Platinum Resistance
The First Hospital of Jilin University
Not applicable
40
Changchun
2025-01-17
Recruiting
The Effect of Different Digestive Tract Reconstruction Methods on Postoperative Quality of Life After Proximal Gastrectomy
NCT06929949Gastroesophageal Junction (GEJ) Cancer, Gastric Cancer
The First Hospital of Jilin University
Observational
90
Changchun
2024-11-25
Recruiting
The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
NCT06881043Locally Advanced Gastric Cancer, Gastric Adenocarcinoma
The First Hospital of Jilin University
Observational
300
Changchun
2024-11-20
Recruiting
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
NCT07439991Lung Cancer (Diagnosis), Deep Vein Thrombosis (DVT), Venous Thromboembolism (VTE)
The First Hospital of Jilin University
Observational
900
Changchun
2024-11-01
Not yet open
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
NCT06595342Cervical Artery Stenosis, Intracranial Artery Stenosis
The First Hospital of Jilin University
Observational
60,000
Changchun
2024-10-30
Recruiting
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
NCT07119463Postoperative Hypoalbuminemia, Postoperative Complications, Gastric Cancer
The First Hospital of Jilin University
Phase 2
112
Changchun
2024-10-29
Recruiting
Hypofractionated Radiotherapy
NCT06740955Glioblastoma
The First Hospital of Jilin University
Not applicable
420
Changchun
2024-08-13
Recruiting
Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)
NCT06592170Lymphoma
The First Hospital of Jilin University
Phase 1/2
35
Changchun
2024-08-13
Active, closed
A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).
NCT06550336Peripheral T Cell Lymphoma
The First Hospital of Jilin University
Phase 2
35
Changchun
2024-06-30
Recruiting
Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke
NCT06045156Acute Ischemic Stroke
The First Hospital of Jilin University
Not applicable
1,084
Changchun
2024-04-29
Recruiting
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262Breast Cancer, MRD
The First Hospital of Jilin University
Observational
40
Changchun
2024-01-01
Not yet open
Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study
NCT05998122Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1
The First Hospital of Jilin University
Phase 2
45
Changchun
2023-09-01
Not yet open
Neurological Sequelae in Patients With Acute Carbon Monoxide Poisoning
NCT04925297Carbon Monoxide Poisoning
The First Hospital of Jilin University
Observational
1,250
Changchun
2021-08-01
Active, closed
Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
NCT04326153IIIA Stage Non-small Cell Lung Cancer
The First Hospital of Jilin University
Phase 2
30
Changchun
2020-03-20
Recruiting
Risk Factors and Predictive Model for Inflammatory Polyps in Ureteral Stones
NCT07559721Ureteral Calculi
The First Hospital of Jilin University
Observational
779
Changchun
2018-01-01
Rows per page Showing 1–47 of 47
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/changchun

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 47 of those studies with a site in Changchun that also match the filters currently applied.

How many clinical trials are recruiting in Changchun?

30 of the 47 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 8 have not yet opened recruitment, 5 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Changchun), 47 studies
PhaseStudiesRecruitingShare
Observational161034%
Not applicable141029.8%
Phase 211623.4%
Phase 4326.4%
Phase 1102.1%
Phase 1/2112.1%
Phase 2/3112.1%

Most active sponsors

Lead sponsors with the most studies (Changchun)
Lead sponsorStudiesRecruiting
The First Hospital of Jilin University4730
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.